272 related articles for article (PubMed ID: 26922065)
1. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Abdullah MP; Ho CL; Omar AR; Ismail J; Alitheen NB
BMC Complement Altern Med; 2016 Feb; 16():86. PubMed ID: 26922065
[TBL] [Abstract][Full Text] [Related]
2. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Zulfadli AJ; Omar AR; Sulaiman MR; Abdullah MP; Alitheen NB
PLoS One; 2014; 9(10):e105244. PubMed ID: 25286005
[TBL] [Abstract][Full Text] [Related]
3. The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B.
Rossette MC; Moraes DC; Sacramento EK; Romano-Silva MA; Carvalho JL; Gomes DA; Caldas H; Friedman E; Bastos-Rodrigues L; De Marco L
Phytother Res; 2017 Oct; 31(10):1607-1613. PubMed ID: 28816367
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB
Drug Des Devel Ther; 2015; 9():1401-17. PubMed ID: 25834398
[TBL] [Abstract][Full Text] [Related]
5. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis.
Ji T; Lin C; Krill LS; Eskander R; Guo Y; Zi X; Hoang BH
Mol Cancer; 2013 Jun; 12():55. PubMed ID: 23764122
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma.
Chaudhary S; Chandrashekar KS; Pai KS; Setty MM; Devkar RA; Reddy ND; Shoja MH
BMC Complement Altern Med; 2015 Mar; 15():50. PubMed ID: 25886964
[TBL] [Abstract][Full Text] [Related]
8. Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.
Pinner KD; Wales CT; Gristock RA; Vo HT; So N; Jacobs AT
Pharm Biol; 2016 Sep; 54(9):1503-12. PubMed ID: 26789234
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer amelioration by Butea monosperma in-vitro and in-vivo.
Karia P; Patel KV; Rathod SSP
J Ethnopharmacol; 2018 May; 217():54-62. PubMed ID: 29366766
[TBL] [Abstract][Full Text] [Related]
10. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.
Eskander RN; Randall LM; Sakai T; Guo Y; Hoang B; Zi X
J Obstet Gynaecol Res; 2012 Aug; 38(8):1086-94. PubMed ID: 22540374
[TBL] [Abstract][Full Text] [Related]
11. Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro.
Celentano A; Yiannis C; Paolini R; Zhang P; Farah CS; Cirillo N; Yap T; McCullough M
Sci Rep; 2020 Sep; 10(1):15904. PubMed ID: 32985597
[TBL] [Abstract][Full Text] [Related]
12. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
[TBL] [Abstract][Full Text] [Related]
13. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis.
Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
Breast Cancer Res Treat; 2004 Mar; 84(2):151-60. PubMed ID: 14999145
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity of extracts and crude saponins from Zanthoxylum armatum DC. against human breast (MCF-7, MDA-MB-468) and colorectal (Caco-2) cancer cell lines.
Alam F; Najum Us Saqib Q; Waheed A
BMC Complement Altern Med; 2017 Jul; 17(1):368. PubMed ID: 28716103
[TBL] [Abstract][Full Text] [Related]
15. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
Zi X; Simoneau AR
Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
[TBL] [Abstract][Full Text] [Related]
16. The kava chalcone flavokawain B exerts inhibitory activity and synergizes with BCL-2 inhibition in malignant B-cell lymphoma.
Zhao M; Jiang X; Fang J; Lin Y; Li Y; Pei R; Ye P; Lu Y; Jiang L
Phytomedicine; 2023 Nov; 120():155074. PubMed ID: 37716033
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
18. Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines.
Sakai T; Eskander RN; Guo Y; Kim KJ; Mefford J; Hopkins J; Bhatia NN; Zi X; Hoang BH
J Orthop Res; 2012 Jul; 30(7):1045-50. PubMed ID: 22213202
[TBL] [Abstract][Full Text] [Related]
19. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
20. Crateva adansonii DC, an African ethnomedicinal plant, exerts cytotoxicity in vitro and prevents experimental mammary tumorigenesis in vivo.
Zingue S; Cisilotto J; Tueche AB; Bishayee A; Mefegue FA; Sandjo LP; Magne Nde CB; Winter E; Michel T; Ndinteh DT; Awounfack CF; Silihe KK; Melachio Tanekou TT; Creczynski-Pasa TB; Njamen D
J Ethnopharmacol; 2016 Aug; 190():183-99. PubMed ID: 27267829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
